Childhood Central Nervous System Embryonal Tumor: Clinical Trials

4 trials for Childhood Central Nervous System Embryonal Tumor, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

4 completed. 4 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 14Completed 4

Follow Childhood Central Nervous System Embryonal Tumor: new trials by email Literature Review of Childhood Central Nervous System Embryonal Tumor trials Research Report on Childhood Central Nervous System Embryonal Tumor

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Vorinostat and Temozolomide in Treating Young Patients With Relapsed or Refractory Primary Brain Tumors or Spinal Cord Tumors
vorinostat, temozolomide, diagnostic laboratory biomarker analysis - Childhood Atypical Teratoid/Rhabdoid Tumor, Childhood Central Nervous System Choriocarcinoma
Phase 1CompletedNational Cancer Institute (NCI)272010-02-012013-05-03
Pazopanib Hydrochloride in Treating Young Patients With Solid Tumors That Have Relapsed or Not Responded to Treatment
pazopanib hydrochloride, pharmacological study - Childhood Central Nervous System Choriocarcinoma, Childhood Central Nervous System Embryonal Tumor
Phase 1CompletedNational Cancer Institute (NCI)552009-06-012013-09-30
Sunitinib in Treating Young Patients With Refractory Solid Tumors
sunitinib malate, pharmacological study, dynamic contrast-enhanced magnetic resonance imaging - Central Nervous System Metastases, Childhood Central Nervous System Choriocarcinoma
Phase 1CompletedNational Cancer Institute (NCI)352006-10-012014-01-28
Combination Chemotherapy in Treating Young Patients With Advanced Solid Tumors
oxaliplatin, fluorouracil, leucovorin calcium - Childhood Central Nervous System Choriocarcinoma, Childhood Central Nervous System Embryonal Tumor
Phase 1CompletedNational Cancer Institute (NCI)422005-09-012013-05-03

Narrower conditions

Optic Nerve Glioma (2)  ·  Astrocytoma (1)  ·  Choroid Plexus Neoplasms (1)  ·  Familial ependymoma (1)  ·  Medulloblastoma (1)  ·  Oligodendroglioma (1)  ·  Paraganglioma, Extra-Adrenal (1)  ·  Rhabdoid Tumor (1)  ·  Spinal Cord Neoplasms (1)

Broader conditions

Cranial Nerve Diseases (2)  ·  Cranial Nerve Neoplasms (2)  ·  Eye Diseases (2)  ·  Glioma (2)  ·  Neoplasms (2)  ·  Neoplasms by Histologic Type (2)  ·  Neoplasms by Site (2)  ·  Neoplasms, Germ Cell and Embryonal (2)  ·  Neoplasms, Glandular and Epithelial (2)  ·  Neoplasms, Nerve Tissue (2)  ·  Neoplasms, Neuroepithelial (2)  ·  Nervous System Diseases (2)  ·  Nervous System Neoplasms (2)  ·  Neuroectodermal Tumors (2)  ·  Optic Nerve Diseases (2)

Interventions

2-phenyl-6-(2'-(4'-(ethoxycarbonyl)thiazolyl))thiazolo(3,2-b)(1,2,4)triazole (1)  ·  Fluorouracil (1)  ·  Leucovorin (1)  ·  Magnetic Resonance Spectroscopy (1)  ·  Oxaliplatin (1)  ·  Sunitinib (1)  ·  Temozolomide (1)  ·  Vorinostat (1)  ·  pazopanib (1)

Sponsors

National Cancer Institute (NCI) (4)

Countries

United States (4)  ·  Canada (2)

Top investigators

Julia Glade-Bender (1)  ·  Lia Gore (1)  ·  Steven DuBois (1)  ·  Trent Hummel (1)

Results publications

PMID 23554030, PMID 23857966, PMID 32623479, PMID 33852135

NIH funding

U01CA097452 (3)